{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoOvYqNYIDA","lastupdate":"2024-03-22T00:00:00.000Z","update_date":"2024-03-22T00:00:00.000Z","lastModified":"Jan 4, 2025","active":1,"confidence_score":100,"confidence_score_reason":"markets","urlname":"geneyx-genomex","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$dtMzc1rkdCASCaWrLI86SecWlS2cBJAhbwvd9dWxoFN2cBvv8yoQUp","name":"Geneyx Genomex","oneliner":"AI-based Genetic Data Analysis Platform","registrar":"515878460","website":"https://geneyx.com","careerspage":"https://geneyx.com/about-us/careers","founded_month":7,"founded_year":2018,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/Geneyx2","youtube":"https://www.youtube.com/channel/UCYKJdDVLwULJFm0h9utStdg","facebook":"https://www.facebook.com/geneyx.io/?modal=admin_todo_tour","linkedin":"https://www.linkedin.com/company/40735774","instagram":""},"social":["https://www.linkedin.com/company/40735774","https://www.youtube.com/channel/UCYKJdDVLwULJFm0h9utStdg","https://www.facebook.com/geneyx.io/?modal=admin_todo_tour","https://twitter.com/Geneyx2"],"flattenedsociallinks":"https://www.linkedin.com/company/40735774|https://www.youtube.com/channel/UCYKJdDVLwULJFm0h9utStdg|https://www.facebook.com/geneyx.io/?modal=admin_todo_tour|https://twitter.com/Geneyx2","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":31,"patent":0,"raised":14000000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["genix","Jenex","Geneyx Genomex Ltd","genyx","geneYX","genex","Geneyx Genomex Ltd.","Genyx","Geneyx Genomex"],"about":"Geneyx is driven by the belief that comprehensive genomic insights are essential for every patient’s care. Its mission is to transform the integration of genomics into healthcare and pharmaceutical research with a sophisticated data analysis platform. Serving a wide range of clients, including hospitals, genetics labs, and life-science companies, Geneyx offers unmatched precision in genetic analysis and research.\n\nGeneyx Analysis is a comprehensive  platform for secondary and tertiary analysis of germline and somatic sequencing data interpretation. This comprehensive tool tailors to all aspects of in-house bioinformatic pipelines but alleviates the complexities of staying current with current genomic information. Its team strives to provide a resource that significantly improves diagnostic yields and turnaround times, and its mission is to provide a platform that achieves a world without undiagnosed diseases. ","climatetech_description":null,"is_climatetech_relevant":null,"phone":"0502552262","country":null,"address":{"israeli":[{"id":"ff24754c-26bf-4ae0-a309-128228ef2f66","city":"Herzliya","type":null,"address":"Galgalei ha-Plada St 11, Herzliya, Israel","placeid":"ChIJyw6NbI1IHRURHLBISUmaHpw","notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"67daf17f-0301-4add-a99d-7d9b7b3cd34d","city":"Wilmington","address":":, 108 W 13th St Suite 100, Wilmington, DE 19801, USA","country":"United States","placeid":"ChIJ07XdBT_9xokRtt81PH-eV0g"}]},"headquarter_address":null,"district":"Center District","news":[{"id":"z7PhdhIDGaRI7LXwYiNQaXrzxf3qSiSdjqWpHWZICjQiWyrOE903Eo","date":"Sep 19, 2024","link":"https://www.calcalistech.com/ctechnews/article/skebb2k6a","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"AI Accelerator","company":"Google","layoffs":null,"summary":"Google has announced the new cohort for its Google for Startups Accelerator: AI First, which includes three Israeli startups: Bagel AI, Dtect Vision, and Geneyx. The program, developed in partnership with Google Cloud, will run for 10 weeks and feature 15 companies in total. Startups will benefit from Google Cloud and Google DeepMind expertise, one-on-one mentorship, group learning sessions, and Google Cloud credits. The initiative aims to help startups harness AI to scale faster and tackle pressing global challenges. Boaz Maoz, Managing Director of Google Cloud Israel, emphasized the transformative potential of AI and Googles commitment to supporting innovative and responsible AI solutions.","partners":["Bagel AI","Dtect Vision","Geneyx"],"customers":[],"investors":[],"confidence":10,"key_topics":["AI","Startups","Google Cloud","Mentorship","Innovation"],"date_of_event":"2024-09-19","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"K89qWbrayzkub5QvkQ7pYf3uW0buMmM4FhgMYkdY3yRPcoJwWXeHtJ","news_summary":"Three Israeli startups selected as part of Google’s new AI First accelerator | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1A2B2tw6FIjLoExfLI45zmHO5Q2XRbjeUUbikknpkPt8pGOwIHjdMy","date":"Mar 13, 2024","link":"https://finance.yahoo.com/news/childrens-mercy-kansas-city-geneyx-141100063.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuYmluZy5jb20v&guce_referrer_sig=AQAAAJ-yWACtnyJaBWrjSa5k0Ka7FRNttrCQnMKGONUHisUAvEocCGwX4IAauQ7WSnzKV2PD42vtl1UocftYRFGIK5SuynevmcW02cTLMTH2VCBewsZTOZ9xSaEsprviXDlbhgQfVdyFrrGTUxsDkwYeN4zPPb2lzzQWO_RGM2R78jpf","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"Partnership, Genomic Research","company":"Childrens Mercy Kansas City, Geneyx Inc., PacBio","layoffs":"N/A","summary":"Childrens Mercy Kansas City and Geneyx Inc. have announced a collaboration to advance genomic research and analysis. The partnership, formalized through a Master Software Subscription and Services Agreement, will allow Childrens Mercy to use Geneyx Analysis in its research institute to analyze, interpret, annotate, and report Long Read sequencing data. The technology will replace rapid exome, chromosomal microarray analysis, and other conventional diagnostic testing as a first-line assessment for critically ill patients with a strong suspicion of genetic disease. The collaboration aims to enhance the ability to analyze and interpret long read genomic data, leading to advancements in pediatric healthcare.","partners":"Geneyx Inc., PacBio","customers":"N/A","investors":"N/A","confidence":9,"key_topics":"Genomic Research, Collaboration, Geneyx Analysis, Long Read Sequencing, Pediatric Healthcare","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Partners","acquisition_amount":"N/A","structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"FInPqyoBCGOdK1fsQOEXsSs5OzfvnqJZnYeisXzT9xHQft913QfVLa","news_summary":"Children's Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"jmbmVvbu3d63LEQDpXyk7i2BvU3GvLDXi3pLglYRaw4rcAsEN1tzQ4","date":"Jun 9, 2023","link":"https://www.businesswire.com/news/home/20230609005355/en/Oxford-Nanopore-Technologies-and-Geneyx-Announce-the-First-Scalable-Software-Solution-to-Advance-the-Future-Clinical-Use-of-Nanopore-Sequencing","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"ZrcTIpCnYiarbcdnWQxsdONoZ4UCBuNzWe673YnPJlLvSoHwCr3bvH","news_summary":"Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"VqZVQHi5jtYx9bjM03AH7DpxHoeoEdHiyrvlPfrLGpltc7vuCH16mT","date":"May 24, 2023","link":"https://gulfnews.com/uae/health/digi7-launches-geneyx-ai-based-solution-at-mediclinic-1.1684923911327","source":"gulfnews.com","visible":1,"analysis":{"tags":"Partnership, AI-based solution","company":"Mediclinic Middle East","layoffs":"N/A","summary":"Mediclinic Middle East has partnered with Geneyx and Digi7 to implement an AI-based solution for next-generation sequencing data for rare and germ line diseases in its patients. The initiative aims to accelerate genetic diagnosis and research in the Middle East. The partnership is expected to improve patient outcomes, increase efficiency, and equip geneticists with the tools to make the best decisions for patient care.","partners":"Geneyx, Digi7","customers":"Patients of Mediclinic Middle East","investors":"N/A","confidence":9,"key_topics":["Geneyx","AI-based solution","Genetic diagnosis","Digi7","Healthcare"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Partners","Customers"],"acquisition_amount":"N/A","structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pBYk5tzUpek9yKe81iS28Sh3QadQLCAvF1MntHJtPSwq5hnqOzN6Wt","news_summary":"Digi7 launches Geneyx' AI-based solution at Mediclinic","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"WnA1rZFKXcJKGvyquyJLdpXr3vc0IcAZA57WbS1d85ghIqT407cwpN","date":"Oct 23, 2022","link":"https://www.geektime.com/geneyx-wants-to-pinpoint-the-bad-parts-in-your-genome/","source":"www.geektime.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"RsemCCXgIhrSV636j3CczYhs6f8JnBChxhqfqmeyK32tEPPhyAbsud","news_summary":"This Israeli startup wants to dive into genomes to improve disease treatment","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"WT355CeKDQ9Kwb6HbiFiGh4GYadM9EEBxntTQJXQoHCth5OHUecomZ","date":"Oct 21, 2022","link":"https://www.geektime.co.il/geneyx-wants-to-pinpoint-the-bad-parts-in-your-genome/?_atscid=7_134353_204082920_2295634_0_Txtetaxjxdshwhus8sp","source":"www.geektime.co.il","visible":1,"analysis":{"tags":"Healthcare, Genomics","company":"Geneyx","layoffs":"Not mentioned","summary":"Israeli startup Geneyx has developed a system that analyzes patients genomic sequences to precisely identify problematic areas and improve treatment. The cloud-based system helps medical teams link disease symptoms with genetic variants. The company was founded in 2018 and has so far raised $10 million, including from Accentures investment arm. Geneyx employs 25 people at its development center in Herzliya and offices in the US, UK, and Italy. To date, it has performed about 150,000 analyses.","partners":"Microsoft for Startups","customers":"Not mentioned","investors":"Accenture","confidence":9,"key_topics":"Genomics, Disease Treatment, Cloud Technology, Genetic Variants, Startup","date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$10 million","structured_issues":"Investment, Expand","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"gEND1TD67atDfIa8ravPftcbYdmg661DB9yhdY3pash4IHsacF7tHc","news_summary":"סטארטאפ ישראלי רוצה לצלול לגנום שלכם, ולשפר את הטיפול במחלות | גיקטיים","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d39ba950-30f6-402d-a78f-d4d3aaaaf6ef","date":"Nov 11, 2021","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3922324,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"funding round, AI, genetic data analysis, expansion, clinical decision-making, biopharmaceutical research","company":"Geneyx Genomex","layoffs":null,"summary":"Israeli startup Geneyx Genomex has closed a $10 million seed round led by Capri Ventures and Accenture Ventures. The company leverages AI to improve risk prediction, diagnostic yield, prognostic prediction, and treatment insights in genetic data analysis. The investment will support Geneyxs global growth and expansion, aiming to achieve a 90% diagnostic yield in the next two years. Geneyx has already been used in over 100,000 cases across 18 countries and cited in more than 50 peer-reviewed publications. Additionally, Geneyx has joined Accenture Ventures Project Spotlight, which offers access to Accentures expertise and enterprise clients. The companies plan to leverage Accentures dataset of 55 million de-identified patient electronic medical records for joint initiatives.","partners":["Accenture Ventures"],"customers":null,"investors":["Capri Ventures","Accenture Ventures"],"confidence":9,"key_topics":["funding round","AI","genetic data analysis","expansion","clinical decision-making"],"date_of_event":"11.11.21","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$10 million","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"xZF9sc5udJq7hH2SocXki8YsL93wfQru30824SptTH3dyNOD5SOVpm","news_summary":"Geneyx raises $10 million seed round for genetic data analysis platform","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"20ae70df-0188-4964-ade3-1cd02b0de38e","date":"Nov 9, 2021","link":"https://www.businesswire.com/news/home/20211109005593/en/Accenture-Invests-in-Geneyx-to-Expand-the-Use-of-Genetic-Data-for-Targeted-and-Personalized-Therapeutics-and-Diagnostics","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"fvepww1WMBSECRaaXulToLAxXx0yscrNeKwPrcbFzM9b5E8ONM12bh","news_summary":"Accenture Invests in Geneyx to Expand the Use of Genetic Data for Targeted and Personalized Therapeutics and Diagnostics","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"2d8f245d-2318-436a-bcb4-8dc14b6638aa","date":"Oct 10, 2020","link":"https://geneyx.com/geneyx-ngs-sequencing-firm-toldot-genetics/","source":"geneyx.com","visible":1,"analysis":{"tags":"acquisition","company":"Geneyx","layoffs":null,"summary":"Geneyx has acquired Toldot Genetics from BATM Advanced Communications and minority shareholders. The acquisition will integrate Toldots next-generation sequencing analysis technology into Geneyxs platform. Former Toldot CEO Dvir Dahary has become chief scientist of Geneyx. The company aims to leverage genetic data for better clinical diagnosis and the development of targeted and personalized therapeutics. Geneyx is part of a public-private consortium in Israel that is collecting and sequencing genomes from COVID-19 patients. Additional articles mention partnerships with Oxford Nanopore Technologies and Digi7, as well as investments from Accenture Ventures and a seed financing round led by Capri Ventures and Accenture Ventures.","partners":"BATM Advanced Communications, Oxford Nanopore Technologies, Digi7","customers":null,"investors":"BATM Advanced Communications, minority shareholders","confidence":8,"key_topics":["Genomic analysis","Next-generation sequencing","Artificial intelligence","Biomedical interpretation","Targeted and personalized therapeutics"],"date_of_event":"June 21, 2023","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition"],"acquisition_amount":null,"structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"lECkkSv9UWbqkaNgzs61Tl0nCpP16bXCe87Ja0X6nN2qDQPqjGfHOg","news_summary":"Geneyx Genomex Acquires NGS Sequencing Analysis Firm Toldot Genetics \" Geneyx","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d3f6922f-1221-452b-afa8-8cc6f7461374","date":"Apr 10, 2020","link":"https://www.genomeweb.com/sequencing/israeli-consortium-launches-patient-sequencing-study-uncover-covid-19-genetic-risk?utm_source=addthis_shares#.XpQZF8gzY2y","source":"www.genomeweb.com","visible":1,"analysis":{"tags":"genomic sequencing","company":"Geneyx","layoffs":null,"summary":"A public-private consortium in Israel, including Geneyx, will collect samples and sequence genomes from thousands of COVID-19 patients to identify genetic factors related to the disease. The project is expected to receive funding of over $1.5 million, with the Israeli Innovation Authority providing approximately $838,500 and BATM offering additional funding. The consortium aims to document clinical findings and sequence the whole genome of COVID-19 patients, focusing on rare cases such as healthy young people who become critically ill and elderly individuals with minor symptoms. Illuminas NovaSeq 6000 and Dragen Whole Genome Pipeline will be used for sequencing, while Geneyxs platform will enable sample collection, genomic data analysis, and storage. The study is expected to produce initial results by June.","partners":["Israel Ministry of Health","Israel Innovation Authority","Sourasky (Ichilov) Medical Center","Rambam Health Care Campus","BATM"],"customers":null,"investors":"BATM","confidence":8,"key_topics":["COVID-19","genetic factors","diagnostic methods","treatment methods","genome sequencing"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pKJ45gDERItrSzNYKVDQKHllQkqciSPzA6mQf0NSJ6Mat4DeVecOWm","news_summary":"Israeli Consortium Launches Patient Sequencing Study to Uncover COVID-19 Genetic Risk Factors","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":10,"techcommunityinvolvement":null,"mediagallery":[{"id":"2086c045-4aba-43b3-9be6-a70ff10af60b","timestamp":"2021-04-12 11:42:30.000000","resources_type":2,"resources_title":"Geneyx Analysis; Introduction to Rare-disorders Analysis and Interpretation","resources_file_name":"bxSq7_JoaEI","alt":"Geneyx Analysis; Introduction to Rare-disorders Analysis and Interpretation logo","imageurl":"https://img.youtube.com/vi/bxSq7_JoaEI/0.jpg","url":"http://youtu.be/bxSq7_JoaEI"},{"id":"b12f64cf-8df7-4013-983d-6949999a9a93","timestamp":"2021-04-12 11:41:18.000000","resources_type":2,"resources_title":"Geneyx data flow model","resources_file_name":"UhhxgCLq1sU","alt":"Geneyx data flow model logo","imageurl":"https://img.youtube.com/vi/UhhxgCLq1sU/0.jpg","url":"http://youtu.be/UhhxgCLq1sU"}],"tags":["clinical-trials","health-information","pharma-companies","data-analytics","laboratories","clinics","privacy-protection","digital-healthcare","doctors","genomics","clinical-data","diagnostics","hospitals","bioinformatics","artificial-intelligence","digital-therapeutics","genetics"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA"],"technologysuccessstory":null,"usecases":[{"id":"73804f1a-6c3b-41ed-abd2-4e63b960af4a","link":"https://geneyx.com/success_stories/","name":"Identifying Novel Mutations Responsible for Colon  Cancer Predisposition","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T19:08:46.103Z","Revenue Growth":3,"Risk Mitigation":4,"Industry Vertical":"Healthcare","ready_for_display":true,"Talent Development":3,"Agility & Innovation":5,"Customer Acquisition":3,"Operational Efficiency":4,"Short Solution Description":"Geneyx Genomex provides a platform for advanced genomic data analysis, enabling the identification of novel mutations responsible for genetic predispositions to diseases like colon cancer, thereby supporting research and clinical diagnostics."}}],"businessmodels":["B2B"],"productstage":"Released","products":["Geneyx Clinical Apps","Geneyx Anakysis","Geneyx Discovery"],"geomarkets":["Africa","Europe","Global","Asia","South America","Americas"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":4,"lastfunding":"$150K","totalrounds":8,"fundingstage":"Seed","totalfunding":"$14M","publicinvestors":4,"lastpublicfunding":150000,"totalpublicrounds":8,"totalpublicfunding":14000000},"team":[{"name":"David Yizhar","email":"david@geneyx.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoJvQypAJDA","bounced":false,"claimed":0,"founder":1,"urlname":"david-yizhar-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgi5OXwggM","position":"Co-founder & CEO","last_name":"Yizhar","claimtoken":"OFGj2kwQM3M0mzZwptaYGzAowpenpOXJGGuIZQeTrlOEpjo2KUY3ym","first_name":"David","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/david-yizhar-23594675/","unsubscribed":false,"is_activeuser":1,"additionalemail":"david.Yitzhak@gmail.com","claimedemaildate":"2024-03-22 13:43:36.000000","initials":"DY","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Raviv Itzhaky","email":"raviv@geneyx.com","phone":"0502552262","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoKvNlYYKDA","bounced":false,"claimed":1,"founder":1,"urlname":"raviv-itzhaky-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgy7C0qAoM","position":"Co-founder & CMO","last_name":"Itzhaky","claimtoken":"7680688de0f2878a107c124ca9868e3ab50041ab6ed9a63d1a153347943b91ef","first_name":"Raviv","picturekey":"$xltgxtZIKa4ukQkJkv8XzGuRObEDtwkndZ8RIsff8KCCGo05mqbKQ3","claimeddate":"2019-09-22","linkedinurl":"https://www.linkedin.com/in/raviv-itzhaky-44862b4/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2019-09-22 13:12:17.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$xltgxtZIKa4ukQkJkv8XzGuRObEDtwkndZ8RIsff8KCCGo05mqbKQ3","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ofer Barnea","email":"ofer@geneyx.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4N7HppEJDA","bounced":false,"claimed":0,"founder":1,"urlname":"ofer-barnea-2","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDggZvJjQsM","position":"Co-founder & Scientific Advisor","last_name":"Barnea","claimtoken":"zjNxT6IoGK79xptNzB8GjFw4tLB6Rzk8pEmgJOGImiBSE8Zejk32j1","first_name":"Ofer","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ofer-yizhar-barnea-36755833/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-03-22 13:43:40.000000","initials":"OB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Sigalit Shachar","email":"sigal@geneyx.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4OeazIUIDA","bounced":false,"claimed":0,"founder":0,"urlname":"sigalit-shachar-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgx-K5ygkM","position":"CFO","last_name":"Shachar","claimtoken":"3nLCFtXeVcm9unHPbIOEH1mnGQHMUI2xfNJfG8vSYhPcx5ZHB5umfd","first_name":"Sigalit","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/sigalit-shachar-68678b42/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-03-22 13:43:48.000000","initials":"SS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Yaron Mazor","email":"yaronm@geneyx.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4IGltIsIDA","bounced":false,"claimed":0,"founder":0,"urlname":"yaron-mazor","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg_r-WlAoM","position":"CTO","last_name":"Mazor","claimtoken":"diS2QqxPGtoTRZity29GVLuAtTWNnqLD6ZkObsevNZk0pTB0Ni9MzM","first_name":"Yaron","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yaron-mazor-1a8a40/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-03-22 13:43:46.000000","initials":"YM","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Hagar Mor-Shaked","email":"hagar@geneyx.com","phone":"","gender":"Female","userid":"IhxXZLiIxSdGtwUlr7Xd5LUlKUGM1KF3ywKtV3iqBJcw7UdqLXYr1J","bounced":false,"claimed":null,"founder":0,"urlname":"hagar-mor-shaked","visible":1,"memberid":"bRXNpYNfDLVFtZ6OSrEAd4d8r5tfgN5H9OUhQGEB5swP2ciOqDNhKF","position":"Chief Product Officer","last_name":"Mor-Shaked","claimtoken":"VZWxxcjVbZeHeJ6GYS8MU3BFo99fhz5AFw12RVLSzGj1uSPcgs0Gcn","first_name":"Hagar","picturekey":"$XpIH9jvqYCnkvS7qkWUkv4hfq0IPRJfNqpnaOxAJPWhR3VQ5xN6XFS.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/hagar-mor-shaked-a20b21227/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-03-22 13:43:50.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$XpIH9jvqYCnkvS7qkWUkv4hfq0IPRJfNqpnaOxAJPWhR3VQ5xN6XFS.jpeg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ya'ara  Unger","email":"yaara@geneyx.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4OGU_YcJDA","bounced":false,"claimed":0,"founder":0,"urlname":"ya-ara-unger","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg4ZSZ6gkM","position":"Bioinformatics Specialist","last_name":"Unger","claimtoken":"0NmzvGITTGiuhtcmTeNsEW3DsOa17cAKajZQlD6EYAk4gYc9Nj2EHk","first_name":"Ya'ara ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yaara-unger/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-03-22 13:43:54.000000","initials":"YU","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPW8rMQKDA","fullname":"Lena Rogovina"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-05-06T00:00:00.000Z","crunchbaseid":"geneyx-genomex","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Yamila Silbert","creator_email":"yamila.urwicz@gmail.com","createdate":"2019-01-22T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Lena Rogovina","affiliatedOrganizations":null,"timeline":[{"id":"9xG43VXpXMb4P2GdDf2EPrqANYlw9gPHyC4rXIi17e0e8qhLYMpOXo","hub":"Google for Startups Accelerator: AI First","date":"Sep 2024","batch":"#1","amount":"Undisclosed","hub_id":"iHPwVdjYupyZVfNOc28TMVdbdH3NlHTbUpwb3ExJH3fp9vFA6lTstk","source":"https://www.calcalistech.com/ctechnews/article/skebb2k6a","enddate":"Dec 2024","hub_type":"Accelerator","eventtype":"GraduationEvent","hub_hidden":true,"investment":[],"hub_fullurl":"/program_page/google-for-startups-accelerator-ai-first","hub_logokey":"$XL4QxhXVA7RXTMatRrgdUNg6YNSg8BGw2Ko6R2IUoP5Ii6NXlEtZ1G.png","hub_urlname":"/program_page/google-for-startups-accelerator-ai-first","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$XL4QxhXVA7RXTMatRrgdUNg6YNSg8BGw2Ko6R2IUoP5Ii6NXlEtZ1G.png","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"Vy9dnXrRfEwhpQoWQPe9ib46XqCQ83S8gNnC9xHWxz204TffSNtKQB","date":"Oct 2023","amount":"$150K","source":"","eventtype":"GrantEvent","granttype":1,"investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":150000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"urvkEEgLcMROGavnMnw3QdTHPAOOKyDyiU3gDLhajfSg5vX6If0qPz","date":"Jul 2023","amount":"$850K","source":"","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"BIRD Foundation","type":"Investor","amount":850000,"hidden":false,"country":"Israel","fullurl":"/investor_page/bird-foundation-1","logokey":"$GlsX9ZAaRkNYGBNBNK2aPM2bDZqDo5fOQpyg5GcoLxx089Kc9vW9cM","tagline":null,"urlname":"/investor_page/bird-foundation-1","isisraeli":1,"investorid":"wkYw2Xa6wWAx2YsZ9ibCjlofkfLroUdqV57jv9Cfoi5vsESiKKOHLp","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"CDYbMyHffbqN9XQZZqTOonlCAGQURtr24TK4gQNAkVWHDNM5noh0zl","fundingsubtype":"Grant Provider","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$GlsX9ZAaRkNYGBNBNK2aPM2bDZqDo5fOQpyg5GcoLxx089Kc9vW9cM","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":850000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"Pu5BT0SLzzOD8KT6Hv61zz4LU82WG2Pgqm37YgQIlhRpywj5Uiqq4z","date":"Jul 2022","amount":"$3M","source":"https://www.digilife.fund/portfolio.php","eventtype":"FundingRoundEvent","investment":[{"name":"DigiLife","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/digilife","logokey":"$OS80RSeaLSkqvAZK6uys5nsQinELal5ZtB2h4GcOiV1AjJ4w5c5w3t.png","tagline":null,"urlname":"/investor_page/digilife","isisraeli":0,"investorid":"UpK9l7dMuWX13bRWn7Whz4geTDCgmKigbi8stpGlBgeiOmqeQbMWrc","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"tpdabvH6dn5qJqaqZPl2pGGvhpL0HqNXw6bUnVtLKAd3YpM5CkxQOr","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OS80RSeaLSkqvAZK6uys5nsQinELal5ZtB2h4GcOiV1AjJ4w5c5w3t.png","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCowLCQCgw","date":"Nov 2021","amount":"$10M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3922324,00.html, https://www.businesswire.com/news/home/20211109005593/en/Accenture-Invests-in-Geneyx-to-Expand-the-Use-of-Genetic-Data-for-Targeted-and-Personalized-Therapeutics-and-Diagnostics","eventtype":"FundingRoundEvent","investment":[{"name":"Accenture Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/accenture-ventures","logokey":"$H3zOcMwPpGs3CA3XzAvLS1BTODAmdDf5QrPBeaj9ZfRKJLj2Vja2At","tagline":"","urlname":"/investor_page/accenture-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJDIo7-uCAw","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"db5c2168-c774-438d-b499-fafcdf6a7d43","fundingsubtype":"Corporate VC","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$H3zOcMwPpGs3CA3XzAvLS1BTODAmdDf5QrPBeaj9ZfRKJLj2Vja2At","leadcaption":"Lead ","followupcaption":""},{"name":"Capri Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/capri-ventures","logokey":"$LJuNFY2GLzKn4sLwQcehDWT8rmP2K5YKiIWClIgtlFZnVx2epOpKIg","tagline":null,"urlname":"/investor_page/capri-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Kee2vAJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"f56cdfd8-37f9-43f2-9f40-4140d2fe251c","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$LJuNFY2GLzKn4sLwQcehDWT8rmP2K5YKiIWClIgtlFZnVx2epOpKIg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCb85aYCww","date":"Mar 2021","amount":"Undisclosed","source":"https://www.linkedin.com/posts/geneyxgenomex_geneyx-team-is-grateful-to-the-israel-innovation-activity-6782222229192101888-y3b1","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"24b1c013-1fd2-472c-8f47-ea94e3b4537d","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCnyMb5CQw","date":"Oct 2020","amount":"Undisclosed","source":"https://www.genomeweb.com/business-news/geneyx-genomex-acquires-ngs-sequencing-analysis-firm-toldot-genetics#.YJd5g7UzY2w","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Toldot Genetics","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6Wg9wJDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/toldot-genetics","acquiredcompany_mna_logokey":"$PjTfHafubC9zxfnLehkxRwTmXV7j1bmpysbm9xVMPVIolo2YU2H6uY","acquiredcompany_mna_urlname":"/company_page/toldot-genetics","acquiredcompany_mna_homepage":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$PjTfHafubC9zxfnLehkxRwTmXV7j1bmpysbm9xVMPVIolo2YU2H6uY","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD60IjaCgw","date":"Jun 2019","amount":"Undisclosed","source":"Added by Raviv Itzhaky","eventtype":"GrantEvent","granttype":1,"investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":1,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCGrZHJCAw","date":"Mar 2019","amount":"Undisclosed","source":"Added by Raviv Itzhaky","eventtype":"GrantEvent","granttype":1,"investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":1,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD60OyHCww","date":"Sep 2018","amount":"Undisclosed","source":"Added by Raviv Itzhaky","eventtype":"FundingRoundEvent","investment":[{"name":"NextLeap Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/nextleap-ventures","logokey":"$rG771X7Dz0RRsVF3Y3H1i2ZDx3LB91f4JFROpA59Xzm7gtM8Ff3yfJ","tagline":null,"urlname":"/investor_page/nextleap-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJH0vM0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"e29085c7-a791-4c81-bd06-b1b8c5f56c60","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$rG771X7Dz0RRsVF3Y3H1i2ZDx3LB91f4JFROpA59Xzm7gtM8Ff3yfJ","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"7/2018","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Geneyx Genomex","logourl":"https://storage.googleapis.com/clean-finder-353810/$dtMzc1rkdCASCaWrLI86SecWlS2cBJAhbwvd9dWxoFN2cBvv8yoQUp","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$dtMzc1rkdCASCaWrLI86SecWlS2cBJAhbwvd9dWxoFN2cBvv8yoQUp","seoabout":"Geneyx is driven by the belief that comprehensive genomic insights are essential for every patient’s care. Its mission is to transform the integration of g...","seoTitle":"Israeli Startup","solutions":[{"title":"Healthcare","description":"Geneyx Genomex provides a platform for advanced genomic data analysis, enabling the identification of novel mutations responsible for genetic predispositions to diseases like colon cancer, thereby supporting research and clinical diagnostics.","items":[{"name":"Revenue Growth","value":3,"titleTooltip":"Revenue Growth & Profitability","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Operational Efficiency","value":4,"titleTooltip":"Operational Excellence & Efficiency","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Customer Acquisition","value":3,"titleTooltip":"Customer Acquisition, Satisfaction & Loyalty","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Risk Mitigation","value":4,"titleTooltip":"Risk Mitigation & Business Resilience","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Talent Development","value":3,"titleTooltip":"Talent Development & Employee Empowerment","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Agility & Innovation","value":5,"titleTooltip":"Strategic Agility & Innovation","meterTooltip":{"title":"Disruptive / Paradigm-Shifting","content":"Revolutionary, industry-leading change that sets new benchmarks and norms."}}]}],"teamMembersNumber":7,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Digital Medical Diagnostics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Genes","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Laboratories","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA>Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Laboratories#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Genes#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Digital Medical Diagnostics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Digital Medical Diagnostics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA|2:>TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA/Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Genes#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Laboratories#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Digital Medical Diagnostics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Digital Medical Diagnostics"},{"title":"Medical Decision Support","key":"0-0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Medical Decision Support"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Laboratories","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Laboratories"},{"title":"Providers","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]},{"title":"Life Sciences","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Platforms & Interfaces","key":"0-0","path":"TechnologyClassificationModel>Platforms & Interfaces","children":[{"title":"Software","key":"0-0-0","path":"TechnologyClassificationModel>Platforms & Interfaces>Software"}]},{"title":"Artificial Intelligence","key":"0-1","path":"TechnologyClassificationModel>Artificial Intelligence"},{"title":"Biologicals","key":"0-2","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Genes","key":"0-2-0","path":"TechnologyClassificationModel>Biologicals>Genes"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Digital Medical Diagnostics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Genes","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Laboratories","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Digital Medical Diagnostics","Medical Decision Support"],"coreTechnology":["Platforms & Interfaces","Software","Artificial Intelligence","Biologicals","Genes"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Laboratories","Providers","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"Pu5BT0SLzzOD8KT6Hv61zz4LU82WG2Pgqm37YgQIlhRpywj5Uiqq4z","date":"Jul 2022","amount":"$3M","source":"https://www.digilife.fund/portfolio.php","eventtype":"FundingRoundEvent","investment":[{"name":"DigiLife","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/digilife","logokey":"$OS80RSeaLSkqvAZK6uys5nsQinELal5ZtB2h4GcOiV1AjJ4w5c5w3t.png","tagline":null,"urlname":"/investor_page/digilife","isisraeli":0,"investorid":"UpK9l7dMuWX13bRWn7Whz4geTDCgmKigbi8stpGlBgeiOmqeQbMWrc","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"tpdabvH6dn5qJqaqZPl2pGGvhpL0HqNXw6bUnVtLKAd3YpM5CkxQOr","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OS80RSeaLSkqvAZK6uys5nsQinELal5ZtB2h4GcOiV1AjJ4w5c5w3t.png","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCowLCQCgw","date":"Nov 2021","amount":"$10M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3922324,00.html, https://www.businesswire.com/news/home/20211109005593/en/Accenture-Invests-in-Geneyx-to-Expand-the-Use-of-Genetic-Data-for-Targeted-and-Personalized-Therapeutics-and-Diagnostics","eventtype":"FundingRoundEvent","investment":[{"name":"Accenture Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/accenture-ventures","logokey":"$H3zOcMwPpGs3CA3XzAvLS1BTODAmdDf5QrPBeaj9ZfRKJLj2Vja2At","tagline":"","urlname":"/investor_page/accenture-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJDIo7-uCAw","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"db5c2168-c774-438d-b499-fafcdf6a7d43","fundingsubtype":"Corporate VC","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$H3zOcMwPpGs3CA3XzAvLS1BTODAmdDf5QrPBeaj9ZfRKJLj2Vja2At","leadcaption":"Lead ","followupcaption":""},{"name":"Capri Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/capri-ventures","logokey":"$LJuNFY2GLzKn4sLwQcehDWT8rmP2K5YKiIWClIgtlFZnVx2epOpKIg","tagline":null,"urlname":"/investor_page/capri-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Kee2vAJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"f56cdfd8-37f9-43f2-9f40-4140d2fe251c","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$LJuNFY2GLzKn4sLwQcehDWT8rmP2K5YKiIWClIgtlFZnVx2epOpKIg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD60OyHCww","date":"Sep 2018","amount":"Undisclosed","source":"Added by Raviv Itzhaky","eventtype":"FundingRoundEvent","investment":[{"name":"NextLeap Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/nextleap-ventures","logokey":"$rG771X7Dz0RRsVF3Y3H1i2ZDx3LB91f4JFROpA59Xzm7gtM8Ff3yfJ","tagline":null,"urlname":"/investor_page/nextleap-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJH0vM0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"e29085c7-a791-4c81-bd06-b1b8c5f56c60","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$rG771X7Dz0RRsVF3Y3H1i2ZDx3LB91f4JFROpA59Xzm7gtM8Ff3yfJ","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"Vy9dnXrRfEwhpQoWQPe9ib46XqCQ83S8gNnC9xHWxz204TffSNtKQB","date":"Oct 2023","amount":"$150K","source":"","eventtype":"GrantEvent","granttype":1,"investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":150000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"urvkEEgLcMROGavnMnw3QdTHPAOOKyDyiU3gDLhajfSg5vX6If0qPz","date":"Jul 2023","amount":"$850K","source":"","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"BIRD Foundation","type":"Investor","amount":850000,"hidden":false,"country":"Israel","fullurl":"/investor_page/bird-foundation-1","logokey":"$GlsX9ZAaRkNYGBNBNK2aPM2bDZqDo5fOQpyg5GcoLxx089Kc9vW9cM","tagline":null,"urlname":"/investor_page/bird-foundation-1","isisraeli":1,"investorid":"wkYw2Xa6wWAx2YsZ9ibCjlofkfLroUdqV57jv9Cfoi5vsESiKKOHLp","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"CDYbMyHffbqN9XQZZqTOonlCAGQURtr24TK4gQNAkVWHDNM5noh0zl","fundingsubtype":"Grant Provider","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$GlsX9ZAaRkNYGBNBNK2aPM2bDZqDo5fOQpyg5GcoLxx089Kc9vW9cM","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":850000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCb85aYCww","date":"Mar 2021","amount":"Undisclosed","source":"https://www.linkedin.com/posts/geneyxgenomex_geneyx-team-is-grateful-to-the-israel-innovation-activity-6782222229192101888-y3b1","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"24b1c013-1fd2-472c-8f47-ea94e3b4537d","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD60IjaCgw","date":"Jun 2019","amount":"Undisclosed","source":"Added by Raviv Itzhaky","eventtype":"GrantEvent","granttype":1,"investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":1,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCGrZHJCAw","date":"Mar 2019","amount":"Undisclosed","source":"Added by Raviv Itzhaky","eventtype":"GrantEvent","granttype":1,"investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":1,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCnyMb5CQw","date":"Oct 2020","amount":"Undisclosed","source":"https://www.genomeweb.com/business-news/geneyx-genomex-acquires-ngs-sequencing-analysis-firm-toldot-genetics#.YJd5g7UzY2w","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":0,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Toldot Genetics","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6Wg9wJDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/toldot-genetics","acquiredcompany_mna_logokey":"$PjTfHafubC9zxfnLehkxRwTmXV7j1bmpysbm9xVMPVIolo2YU2H6uY","acquiredcompany_mna_urlname":"/company_page/toldot-genetics","acquiredcompany_mna_homepage":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$PjTfHafubC9zxfnLehkxRwTmXV7j1bmpysbm9xVMPVIolo2YU2H6uY","exit_label":"","po_label":"Public Offering","acquireddesc":"Acquired","sectionname":"Merger & Acquisitions","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"others":[]}}